Atazanavir Sulphate
A complex organic substance that works as an HIV protease inhibitor, which limits the virus’ ability to replicate. With few side effects and a good tolerability, Atazanir was approved by the FDA in 2003 and the EU in 2004.
Formula: C38H52N6O7 • H2SO4
Molecular weight: 802.94 g/mol
Molecular size: Small
Controlled Substance: No
Precursor: No
Indications: Antivirals for systemic use
Status: Commercial
Axano Pharmaceuticals Ltd
- malta europe
- admin @axanopharmamalta.com
- [email protected]
- contact details
- Malta +356 27780827